Chromosome aberrations in solid tumors

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506

Mutations of the BRAF gene in human cancer

Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674

Gene expression profiling predicts clinical outcome of breast cancer

van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474

Real time quantitative PCR.Preprint

Heid, C., Stevens, J., Livak, K. J., & Williams, P. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,180

The fundamental role of epigenetic events in cancer

Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785

Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors

Kallioniemi, A. H., Kallioniemi, O., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,293

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224

Absolute quantification of somatic DNA alterations in human cancer

Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T. I., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,031

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,309

Dissecting the metastatic cascade

Pantel, K., & Brakenhoff, R. H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1370 · Cited by 1,306

Mechanisms of receptor tyrosine kinase activation in cancer

Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066

microRNAs exhibit high frequency genomic alterations in human cancer

Zhang, L., Huang, J., Yang, N., Greshock, J. D., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,043

Essential role for nuclear PTEN in maintaining chromosomal integrity

Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979

TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT

Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 1,006

Autophagy suppresses tumor progression by limiting chromosomal instabilityPreprint

Mathew, R., Kongara, S., Beaudoin, B., Karp, C. M., Bray, K., Degenhardt, K., Chen, G., Jin, S., & White, E. (2007) · Genes & Development · doi:10.1101/gad.1545107 · Cited by 971

Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesisPreprint

Karantza‐Wadsworth, V., Patel, S. A., Kravchuk, O., Chen, G., Mathew, R., Jin, S., & White, E. (2007) · Genes & Development · doi:10.1101/gad.1565707 · Cited by 865

From polyploidy to aneuploidy, genome instability and cancer

Štorchová, Z., & Pellman, D. S. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1276 · Cited by 822

Chromosome 21 and Down syndrome: from genomics to pathophysiology

Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703

Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562

Gene amplification in cancer

Albertson, D. G. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.06.007 · Cited by 533

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions

Hupé, P., Stransky, N., Thiery, J. P., Radvanyi, F., & Barillot, E. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth418 · Cited by 521

High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotypingPreprint

Peiffer, D. A., Le, J. M., Steemers, F. J., Chang, W., Jenniges, T., Garcia, F., Haden, K., Li, J., Shaw, C. A., Belmont, J. W., et al. (2006) · Genome Research · doi:10.1101/gr.5402306 · Cited by 519

Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences

Stark, J. M., Pierce, A. J., Oh, J., Pastink, A., & Jasin, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9305-9316.2004 · Cited by 501

A Genetic Screen for Candidate Tumor Suppressors Identifies REST

Westbrook, T. F., Martin, E. S., Schlabach, M. R., Leng, Y., Liang, A. C. T., Feng, B., Zhao, J. J., Roberts, T. M., Mandel, G., Hannon, G. J., et al. (2005) · Cell · doi:10.1016/j.cell.2005.03.033 · Cited by 492

The new cytogenetics: blurring the boundaries with molecular biology

Speicher, M. R., & Carter, N. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1692 · Cited by 475

Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening

Sawey, E. T., Chanrion, M., Cai, C., Wu, G., Zhang, J., Zender, L., Zhao, A. S., Busuttil, R. W., Yee, H. T., Stein, L. D., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.040 · Cited by 437

Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

Sheffer, M., Bacolod, M. D., Zuk, O., Giardina, S. F., Pinças, H., Barany, F., Paty, P. B., Gerald, W. L., Notterman, D. A., & Domany, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902232106 · Cited by 415

Aneuploidy: Cells Losing Their Balance

Torres, E. M., Williams, B. R., & Amon, A. (2008) · Genetics · doi:10.1534/genetics.108.090878 · Cited by 410

A Modified Bayes Information Criterion with Applications to the Analysis of Comparative Genomic Hybridization Data

Zhang, N. R., & Siegmund, D. O. (2007) · Biometrics · doi:10.1111/j.1541-0420.2006.00662.x · Cited by 407

Human cancers express mutator phenotypes: origin, consequences and targeting

Loeb, L. A. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3063 · Cited by 402

Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

Drilon, A. E. D. C., Cappuzzo, F., Ou, S. I., & Camidge, D. R. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.014 · Cited by 393

Telomere Biology and Human Phenotype

Turner, K. J., Vasu, V., & Griffin, D. K. (2019) · Cells · doi:10.3390/cells8010073 · Cited by 415

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

Lax, S. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0947-3 · Cited by 382

Genomic microarrays in human genetic disease and cancer

Albertson, D. G., & Pinkel, D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg261 · Cited by 371

Identification of Aneuploidy-Tolerating Mutations

Torres, E. M., Dephoure, N., Panneerselvam, A., Tucker, C. M., Whittaker, C. A., Gygi, S. P., Dunham, M. J., & Amon, A. (2010) · Cell · doi:10.1016/j.cell.2010.08.038 · Cited by 369

Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer

Mitelman, F., Johansson, B., & Mertens, F. (2004) · Nature Genetics · doi:10.1038/ng1335 · Cited by 361

A statistical approach for array CGH data analysis

Picard, F., Robin, S. S., Lavielle, M., Vaisse, C., & Daudin, J. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-27 · Cited by 356

Human cancers express a mutator phenotype

Bielas, J. H., Loeb, K. R., Rubin, B. P., True, L. D., & Loeb, L. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607057103 · Cited by 354

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

Li, Y., Zou, L., Li, Q., Haibe‐Kains, B., Tian, R., Li, Y., Desmedt, C., Sotiriou, C. P., Szállási, Z., Iglehart, J. D., et al. (2010) · Nature Medicine · doi:10.1038/nm.2090 · Cited by 348

Identification of Aneuploidy-Selective Antiproliferation Compounds

Tang, Y.-C., Williams, B. R., Siegel, J. J., & Amon, A. (2011) · Cell · doi:10.1016/j.cell.2011.01.017 · Cited by 328

Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter

Krohn, K., Führer, D., Bayer, Y., Eszlinger, M., Brauer, V. F. H., Neumann, S., Paschke, R., & Führer‐Sakel, D. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0005 · Cited by 312

Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA

Ding, J., Huang, S., Wu, S., Zhao, Y., Liang, L., Yan, M., Ge, C., Yao, J., Chen, T., Wan, D., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2039 · Cited by 307

Breast tumor copy number aberration phenotypes and genomic instability

Fridlyand, J., Snijders, A. M., Ylstra, B., Li, H., Olshen, A. B., Segraves, R., Dairkee, S. H., Tokuyasu, T. A., Ljung, B., Jain, A. N., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-96 · Cited by 300

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

Hussenet, T., Dali, S., Exinger, J., Monga, B., Jost, B., Dembélé, D., Martinet, N., Thibault-Carpentier, C., Huelsken, J., Brambilla, E. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008960 · Cited by 301

Significance, detection and markers of disseminated breast cancer cells

Lacroix, M. (2006) · Endocrine Related Cancer · doi:10.1677/erc-06-0001 · Cited by 295

Predicting protein druggability

Hajduk, P. J., Huth, J. R., & Tse, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03624-x · Cited by 293

miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway

Alajez, N. M., Lenarduzzi, M., Ito, E., Hui, A. B., Shi, W., Bruce, J., Yue, S., Huang, S. H., Xu, W., Waldron, J. N., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2754 · Cited by 283

Relationship of Gene Expression and Chromosomal Abnormalities in Colorectal Cancer

Tsafrir, D., Bacolod, M. D., Selvanayagam, Z., Tsafrir, I., Shia, J., Zeng, Z., Liu, H., Krier, C., Stengel, R. F., Barany, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2569 · Cited by 279

Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma

Snijders, A. M., Schmidt, B. L., Fridlyand, J., Dekker, N. P., Pinkel, D., Jordan, R. C., & Albertson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208601 · Cited by 279

Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications

Otmani, K., & Lewalle, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.708765 · Cited by 297

Whole genome DNA copy number changes identified by high density oligonucleotide arrays

Huang, J., Wei, W., Zhang, J., Liu, G., Bignell, G. R., Stratton, M. R., Futreal, P. A., Wooster, R., Jones, K. W., & Shapero, M. H. (2004) · Human Genomics · doi:10.1186/1479-7364-1-4-287 · Cited by 279

NLRC5/MHC class I transactivator is a target for immune evasion in cancer

Yoshihama, S., Roszik, J., Downs, I., Meissner, T. B., Vijayan, S., Chapuy, B., Sidiq, T., Shipp, M. A., Lizee, G. A., & Kobayashi, K. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602069113 · Cited by 276

Loss of pRB causes centromere dysfunction and chromosomal instabilityPreprint

Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 247

Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer.

Peng, J., Zhu, J., Bergamaschi, A., Han, W., Noh, D., Pollack, J. R., & Wang, P. (2010) · PubMed · doi:10.1214/09-aoas271supp · Cited by 232

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells

Soh, J., Okumura, N., Lockwood, W. W., Yamamoto, H., Shigematsu, H., Zhang, W., Chari, R., Shames, D. S., Tang, X., MacAulay, C. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007464 · Cited by 227

Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer

Peng, J., Zhu, J., Bergamaschi, A., Han, W., Noh, D.-Y., Pollack, J. R., & Wang, P. (2010) · The Annals of Applied Statistics · doi:10.1214/09-aoas271 · Cited by 211

Cell Fusion as a Hidden Force in Tumor Progression

Lü, X., & Kang, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2159 · Cited by 212

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

Koorstra, J.-B. M., Karikari, C. A., Feldmann, G., Bisht, S., Rojas, P. L., Offerhaus, G. J. A., Alvarez, H., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.7.7923 · Cited by 208

Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays

Popova, T. G., Manié, É., Stoppa‐Lyonnet, D., Rigaill, G. J., Barillot, E., & Stern, M. (2009) · Genome biology · doi:10.1186/gb-2009-10-11-r128 · Cited by 199

RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis

Fiore, R. D., D’Anneo, A., Tesoriere, G., & Vento, R. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24329 · Cited by 211

New Insights into the Troubles of Aneuploidy

Siegel, J. J., & Amon, A. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155807 · Cited by 209

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes

Narayan, G., Bourdon, V., Chaganti, S. R., Arias‐Pulido, H., Nandula, S. V., Rao, P. H., Gissmann, L., Dürst, M., Schneider, A., Pothuri, B., et al. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20418 · Cited by 201

Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas

Kuo, K., Guan, B., Feng, Y., Mao, T., Chen, X., Jinawath, N., Wang, Y., Kurman, R. J., Shih, I., & Wang, T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3913 · Cited by 199

Discovering and understanding oncogenic gene fusions through data intensive computational approaches

Latysheva, N. S., & Babu, M. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw282 · Cited by 201

Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer

Artandi, S. E., & Attardi, L. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.211 · Cited by 194

A genetic progression model of oral cancer: current evidence and clinical implications

Braakhuis, B. J. M., Leemans, C. R., & Brakenhoff, R. H. (2004) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2004.00225.x · Cited by 190

Expanding the computational toolbox for mining cancer genomes

Ding, L., Wendl, M. C., McMichael, J. F., & Raphael, B. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3767 · Cited by 188

Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution

Heng, H. H., Bremer, S. W., Stevens, J. B., Horne, S. D., Liu, G., Abdallah, B. Y., Ye, K. J., & Ye, C. J. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9427-7 · Cited by 191

Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer

Cheng, Q., Chang, J. T., Geradts, J., Neckers, L. Μ., Haystead, T., Spector, N. L., & Lyerly, H. K. (2012) · Breast Cancer Research · doi:10.1186/bcr3168 · Cited by 185

Biophysical models of tumour growth

Tracqui, P. (2009) · Reports on Progress in Physics · doi:10.1088/0034-4885/72/5/056701 · Cited by 191

Inflammation, proteases and cancer

van Kempen, L. C. L. T., de Visser, K. E., & Coussens, L. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.004 · Cited by 181

Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer

Sun, X., Frierson, H. F., Chen, C., Li, C., Ran, Q., Otto, K. B., Cantarel, B. L., Vessella, R. L., Gao, A. C., Petros, J. A., et al. (2005) · Nature Genetics · doi:10.1038/ng1528 · Cited by 174

Genetic alterations of histone lysine methyltransferases and their significance in breast cancer

Liu, L., Kimball, S., Liu, H., Holowatyj, A., & Yang, Z.-Q. (2014) · Oncotarget · doi:10.18632/oncotarget.2967 · Cited by 178

Cancer cells preferentially lose small chromosomes

Duijf, P. H. G., Schultz, N. D., & Benezra, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27924 · Cited by 175

Functional Copy-Number Alterations in Cancer

Taylor, B. S., Barretina, J., Socci, N. D., DeCarolis, P., Ladanyi, M., Meyerson, M., Singer, S., & Sander, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003179 · Cited by 170

Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos

Potapova, T., Zhu, J., & Li, R. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9436-6 · Cited by 170

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways Predict Clinical Outcomes in Esophageal Cancer

Wu, X., Gu, J. H., Wu, T., Swisher, S. G., Liao, Z., Correa, A. M., Liu, J., Etzel, C. J., Amos, C. I., Huang, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6640 · Cited by 166

The Cellular and Molecular Carcinogenic Effects of Radon Exposure: A Review

Robertson, A., Allen, J., Laney, R., & Curnow, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714024 · Cited by 165

When, where and how the bridge breaks: anaphase bridge breakage plays a crucial role in gene amplification and HSR generation

Shimizu, N., Shingaki, K., Kaneko-Sasaguri, Y., Hashizume, T., & Kanda, T. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.001 · Cited by 163

The Pattern of Gene Amplification Is Determined by the Chromosomal Location of Hairpin-Capped Breaks

Narayanan, V., Mieczkowski, P. A., Kim, H., Petes, T. D., & Lobachev, K. S. (2006) · Cell · doi:10.1016/j.cell.2006.04.042 · Cited by 162

Stochastic cancer progression driven by non‐clonal chromosome aberrations

Heng, H. H., Stevens, J. B., Liu, G., Bremer, S. W., Ye, K. J., Reddy, P.-V., Wu, G. S., Wang, Y., Tainsky, M. A., & Ye, C. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20685 · Cited by 165

Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Lee, G. Y., Haverty, P. M., Li, L., Kljavin, N. M., Bourgon, R., Lee, J., Stern, H. M., Modrusan, Z. D., Seshagiri, S., Zhang, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2683 · Cited by 164

MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century

Matushansky, I., Charytonowicz, E., Mills, J. E., Siddiqi, S., Hricik, T., & Cordon‐Cardo, C. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.76 · Cited by 162

Chromosome Fragmentation after Induction of a Double-Strand Break Is an Active Process Prevented by the RMX Repair Complex

Lobachev, K. S., Vitriol, E. A., Stemple, J., Resnick, M. A., & Bloom, K. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.051 · Cited by 155

Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomesPreprint

Kim, T., Xi, R., Luquette, L. J., Park, R. W., Johnson, M. D., & Park, P. J. (2012) · Genome Research · doi:10.1101/gr.140301.112 · Cited by 152

An evaluation of copy number variation detection tools for cancer using whole exome sequencing data

Zare, F., Dow, M. T., Monteleone, N. J., Hosny, A., & Nabavi, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1705-x · Cited by 149

DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control

Chang, P.-C., Cw, C., Chau, G.-Y., Li, F.-Y., Tsai, Y.-H., Wu, J.-C., & Lee, Y.-H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1209239 · Cited by 151

Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women

Çolak, D., Nofal, A., AlBakheet, A., Nirmal, M. S., Jeprel, H. A., Eldali, A., Al‐Tweigeri, T., Tulbah, A. M., Ajarim, D. S., Malik, O. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063204 · Cited by 146

Mechanisms leading to chromosomal instability

Gollin, S. M. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.09.004 · Cited by 143

Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays

Staaf, J., Lindgren, D., Vallon‐Christersson, J., Isaksson, A., Göransson, H., Juliusson, G., Rosenquist, R., Höglund, M., Borg, Å., & Ringnér, M. (2008) · Genome biology · doi:10.1186/gb-2008-9-9-r136 · Cited by 143

Genetic and epigenetic heterogeneity in cancer: A genome‐centric perspective

Heng, H. H., Bremer, S. W., Stevens, J. B., Ye, K. J., Liu, G., & Ye, C. J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21799 · Cited by 142

Amplicon profiles in ovarian serous carcinomas

Nakayama, K., Nakayama, N., Jinawath, N., Salani, R., Kurman, R. J., Shih, I., & Wang, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22609 · Cited by 139

Telomere dysfunction, genome instability and cancer

Annie, L. M. C. (2007) · Frontiers in bioscience · doi:10.2741/2825 · Cited by 137

Integrated global profiling of cancer

Hanash, S. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1414 · Cited by 136

KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer

Bloch, M., Ousingsawat, J., Simon, R., Schraml, P., Gasser, T. C., Mihatsch, M. J., Kunzelmann, K., & Bubendorf, L. (2006) · Oncogene · doi:10.1038/sj.onc.1210036 · Cited by 138

Circulating tumor cell is a common property of brain glioma and promotes the monitoring system

Gao, F., Cui, Y., Jiang, H., Sui, D., Wang, Y., Jiang, Z., Zhao, J., & Lin, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11114 · Cited by 133

Sparse representation and Bayesian detection of genome copy number alterations from microarray data

Piqué-Regi, R., Monso-Varona, J., Ortega, A., Seeger, R. C., Triche, T. J., & Asgharzadeh, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm601 · Cited by 131

HER2 overexpression correlates with survival after curative resection of pancreatic cancer

Komoto, M., Nakata, B., Amano, R., Yamada, N., Yashiro, M., Ohira, M., Wakasa, K., & Hirakawa, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01176.x · Cited by 126

DNA copy number amplification profiling of human neoplasms

Myllykangas, S., Himberg, J., Böhling, T., Nagy, B., Hollmén, J., & Knuutila, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209717 · Cited by 124

The molecular genetics of breast cancer: The contribution of comparative genomic hybridization

Reis-Filho, J. S., Simpson, P. T., Gale, T., & Lakhani, S. R. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2005.05.013 · Cited by 123

Integrative Analysis of Genomic Aberrations Associated with Prostate Cancer Progression

Kim, J. H., Dhanasekaran, S. M., Mehra, R., Tomlins, S. A., Gu, W., Yu, J., Kumar‐Sinha, C., Cao, X., Dash, A., Wang, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1297 · Cited by 119

SOX2 amplification is a common event in squamous cell carcinomas of different organ sites

Maier, S. H., Wilbertz, T., Braun, M., Scheble, V. J., Reischl, M., Mikut, R., Menon, R., Nikolov, P., Petersen, K., Beschorner, C., et al. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.11.010 · Cited by 121

Is carcinogenesis a form of speciation?

DUESBERG, P. H., Mandrioli, D., McCormack, A. A., & Nicholson, J. M. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16352 · Cited by 126

The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy

Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120

Integrated study of copy number states and genotype calls using high-density SNP arrays

Sun, W., Wright, F. A., Tang, Z.-Z., Nord, S., Loo, P. V., Yu, T., Kristensen, V. N., & Perou, C. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp493 · Cited by 121

Inferring copy number and genotype in tumour exome data

Amarasinghe, K. C., Li, J., Hunter, S. M., Ryland, G. L., Cowin, P. A., Campbell, I., & Halgamuge, S. K. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-732 · Cited by 119

chromosome aberrations in human

Anderson, R. M., Stevens, D. L., Sumption, N. D., Stuart, K. M., GOODHEAD, D. T., Hill, M. A., Rhona, C., & Anderson, M. (2014)

Stage specific chromosomal aberrations in solid tumor progression

Ried, T., Schröck, E., Heselmeyer, K. M., du Manoir, S., Macville, M. V. E., & Auer, G. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)90242-9

Clinical relevance of chromosome aberrations in soft tissue tumours

Turc‐Carel, C., Coindre, J., Terrier, P., Frigere, M. F., Haus, O., & Huffermann, K. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90432-8 · Cited by 2

Chromosome aberrations in human breast tumors

Stamper, S. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90397-3 · Cited by 1

Chromosome 12 aberrations in human solid tumors cytogenetics and molecular genetics

Bullerdiek, J. (1994)